amfenac and nepafenac
amfenac has been researched along with nepafenac in 6 studies
Research
Studies (6)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Ernest, P; Gayton, J; Lehmann, R; Raizman, M; Walters, T | 1 |
| Bucci, FA; Waterbury, LD | 1 |
| Erdahl, WE; Gadd, ME; Graff, G; Kumar, J; Lal, N; Pfeiffer, DR; Yanni, JM | 1 |
| Bingaman, DP; Clark, ML; Penn, JS; Yang, R; Yanni, SE | 1 |
| Bucolo, C; Drago, F; Marrazzo, G; Platania, CB; Romano, GL; Salomone, S | 1 |
| Chastain, JE; Chemuturi, NV; Curtis, MA; Dahlin, DC; Gadd, ME; Kapin, MA; Markwardt, KL; Sanders, ME | 1 |
Trials
1 trial(s) available for amfenac and nepafenac
| Article | Year |
|---|---|
In vivo pharmacokinetics and in vitro pharmacodynamics of nepafenac, amfenac, ketorolac, and bromfenac.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aqueous Humor; Area Under Curve; Benzeneacetamides; Benzophenones; Biological Availability; Bromobenzenes; Cataract Extraction; Chromatography, High Pressure Liquid; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase Inhibitors; Dinoprostone; Double-Blind Method; Female; Humans; Ketorolac; Male; Middle Aged; Phenylacetates | 2007 |
Other Studies
5 other study(ies) available for amfenac and nepafenac
| Article | Year |
|---|---|
Re: Pharmacokinetics and pharmacodynamics of nepafenac, amfenac, ketorolac, and bromfenac.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aqueous Humor; Area Under Curve; Benzeneacetamides; Benzophenones; Biological Availability; Bromobenzenes; Cataract Extraction; Chromatography, High Pressure Liquid; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase Inhibitors; Dinoprostone; Humans; Ketorolac; Phenylacetates | 2008 |
Differential effects of non-steroidal anti-inflammatory drugs on mitochondrial dysfunction during oxidative stress.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Benzeneacetamides; Benzophenones; Bromobenzenes; Celecoxib; Diclofenac; Ketorolac Tromethamine; Male; Membrane Potentials; Mitochondria, Liver; Molecular Structure; Oxidative Stress; Permeability; Phenylacetates; Pyrazoles; Rats; Rats, Sprague-Dawley; Sulfonamides; Temperature; Time Factors | 2009 |
The effects of nepafenac and amfenac on retinal angiogenesis.
Topics: Analysis of Variance; Animals; Animals, Newborn; Anti-Inflammatory Agents, Non-Steroidal; Benzeneacetamides; Celecoxib; Cell Proliferation; Cyclooxygenase Inhibitors; Dinoprostone; Disease Models, Animal; Dose-Response Relationship, Drug; Epithelial Cells; Gene Expression Regulation; Humans; Neuroglia; Oxygen; Phenylacetates; Prostaglandins; Pyrazoles; Rats; Rats, Long-Evans; Rats, Sprague-Dawley; Retina; Retinal Neovascularization; Retinal Vessels; Sulfonamides; Vascular Endothelial Growth Factor A | 2010 |
Effects of topical indomethacin, bromfenac and nepafenac on lipopolysaccharide-induced ocular inflammation.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Benzeneacetamides; Benzophenones; Bromobenzenes; Cyclooxygenase 2; Dinoprostone; Indomethacin; Inflammation; Lipopolysaccharides; Male; Phenylacetates; Rats, Sprague-Dawley; Retina; Retinal Hemorrhage; Uveitis | 2014 |
Distribution of topical ocular nepafenac and its active metabolite amfenac to the posterior segment of the eye.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Benzeneacetamides; Chromatography, High Pressure Liquid; Disease Models, Animal; Instillation, Drug; Macaca fascicularis; Male; Ophthalmic Solutions; Phenylacetates; Posterior Eye Segment; Rabbits; Tissue Distribution; Uveitis, Posterior | 2016 |